These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 31370111)
1. Fu Q; Gao L; Fu X; Meng Q; Lu Z J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111 [No Abstract] [Full Text] [Related]
2. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration. Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068 [TBL] [Abstract][Full Text] [Related]
3. Lee YG; Park JH; Jeon ES; Kim JH; Lim BK J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433 [TBL] [Abstract][Full Text] [Related]
4. ORI2 inhibits coxsackievirus replication and myocardial inflammation in experimental murine myocarditis. Lim BK; Kim JH Biol Pharm Bull; 2014; 37(10):1650-4. PubMed ID: 25273388 [TBL] [Abstract][Full Text] [Related]
5. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice. Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. Zhou L; He X; Gao B; Xiong S J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170 [TBL] [Abstract][Full Text] [Related]
7. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication. Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210 [TBL] [Abstract][Full Text] [Related]
8. Baicalein suppresses Coxsackievirus B3 replication by inhibiting caspase-1 and viral protease 2A. Dong Y; Shao E; Li S; Wang R; Wang D; Wang L; Yang H; He Y; Luan T; Chen Y; Wang Y; Lin L; Wang Y; Zhong Z; Zhao W Virol Sin; 2024 Aug; 39(4):685-693. PubMed ID: 39025463 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes. Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926 [TBL] [Abstract][Full Text] [Related]
10. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response. Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842 [TBL] [Abstract][Full Text] [Related]
11. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways. Wang X; Li M; Yu Y; Liu G; Yu Y; Zou Y; Ge J; Chen R J Cell Physiol; 2019 Aug; 234(10):18029-18040. PubMed ID: 30843214 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3. Wang Y; Zhuan X; Peng Y; Li Q; Huang C; Huang H; Liang Z; Wang Q; Chang J Acta Virol; 2021; 65(1):58-67. PubMed ID: 33827222 [TBL] [Abstract][Full Text] [Related]
13. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy. Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319 [TBL] [Abstract][Full Text] [Related]
14. Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model. Kim HG; Hillman PF; Lee YJ; Jeon HE; Lim BK; Nam SJ Viruses; 2024 Apr; 16(5):. PubMed ID: 38793559 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3. Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124 [TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma. Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755 [TBL] [Abstract][Full Text] [Related]
18. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury. Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471 [TBL] [Abstract][Full Text] [Related]
19. The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway. He F; Xiao Z; Yao H; Li S; Feng M; Wang W; Liu Z; Liu Z; Wu J J Transl Med; 2019 Oct; 17(1):335. PubMed ID: 31585536 [TBL] [Abstract][Full Text] [Related]
20. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis. Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]